These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8376682)

  • 1. Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators.
    Colucci WS; Sonnenblick EH; Adams KF; Berk M; Brozena SC; Cowley AJ; Grabicki JM; Kubo SA; LeJemtel T; Littler WA
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):113A-118A. PubMed ID: 8376682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
    Packer M
    Am J Cardiol; 1989 Jan; 63(2):41A-45A. PubMed ID: 2642629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic achievements of phosphodiesterase inhibitors and the future.
    Jewitt DE
    Eur Heart J; 1989 Aug; 10 Suppl C():53-9. PubMed ID: 2680498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical results with oral milrinone in heart failure.
    DiBianco R
    Eur Heart J; 1989 Aug; 10 Suppl C():44-52. PubMed ID: 2680497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors.
    Milfred-LaForest SK; Shubert J; Mendoza B; Flores I; Eisen HJ; Piña IL
    Am J Cardiol; 1999 Oct; 84(8):894-9. PubMed ID: 10532506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
    Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study.
    Eichhorn EJ; Tandon PK; DiBianco R; Timmis GC; Fenster PE; Shannon J; Packer M
    J Am Coll Cardiol; 1993 Mar; 21(3):634-40. PubMed ID: 8436744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine.
    Hood WB
    Am J Cardiol; 1989 Jan; 63(2):46A-53A. PubMed ID: 2521268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.
    Corbalán R; Jalil J; Chamorro G; Casanegra P; Valenzuela P
    Am J Cardiol; 1990 Mar; 65(9):644-9. PubMed ID: 2178384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    Liu L; Zhao SP
    Int J Cardiol; 1999 Apr; 69(1):77-82. PubMed ID: 10362376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
    Dobashi S; Watanabe I; Nakanishi R; Hisatake S; Kiuchi S; Kabuki T; Oka T; Fujii T; Ikeda T
    Heart Vessels; 2020 Jun; 35(6):776-785. PubMed ID: 31865433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    Thackray S; Witte K; Clark AL; Cleland JG
    Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group.
    Goldberg AD; Nicklas J; Goldstein S
    Am J Cardiol; 1991 Sep; 68(6):631-6. PubMed ID: 1715125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors.
    Wood MA; Hess ML
    Am J Med Sci; 1989 Feb; 297(2):105-13. PubMed ID: 2521982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with severe congestive heart failure treated with oral milrinone.
    Baim DS; Colucci WS; Monrad ES; Smith HS; Wright RF; Lanoue A; Gauthier DF; Ransil BJ; Grossman W; Braunwald E
    J Am Coll Cardiol; 1986 Mar; 7(3):661-70. PubMed ID: 3950244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.